We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+13.06%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$8.1B
AUM Growth
+$4.9B
Cap. Flow
+$4.22B
Cap. Flow %
52.11%
Top 10 Hldgs %
26.76%
Holding
6,444
New
505
Increased
3,426
Reduced
1,637
Closed
524

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$314M
2
AAPL icon
Apple
AAPL
+$247M
3
MSFT icon
Microsoft
MSFT
+$235M
4
AMZN icon
Amazon
AMZN
+$110M
5
NVDA icon
NVIDIA
NVDA
+$99M

Sector Composition

Rank Sector Weight
1 Technology 26.14%
2 Financials 11.29%
3 Healthcare 10.69%
4 Consumer Discretionary 10.28%
5 Industrials 7.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PXLW icon
4776
Pixelworks
PXLW
$38.3M
$6.18K ﹤0.01%
393
+10
+3% +$145
CGEN icon
4777
Compugen
CGEN
$221M
$6.17K ﹤0.01%
+3,114
New +$2.72K
RCAT icon
4778
Red Cat Holdings
RCAT
$1.63B
$6.16K ﹤0.01%
6,999
+5,997
+599% +$5.15K
NVIV
4779
DELISTED
InVivo Therapeutics Holdings Corp
NVIV
$6.13K ﹤0.01%
8,395
+802
+11% +$680
RJET
4780
Republic Airways Holdings
RJET
$976M
$6.12K ﹤0.01%
+404
New +$4.8K
ASNS
4781
DELISTED
ACTELIS NETWORKS INC
ASNS
$6.12K ﹤0.01%
546
-58
-10% -$676
GHSI
4782
DELISTED
Guardion Health Sciences, Inc. Common Stock
GHSI
$6.08K ﹤0.01%
1,138
+171
+18% +$1.04K
FEED
4783
ENvue Medical Inc
FEED
$3.7M
$6.05K ﹤0.01%
48
+20
+71% +$2.45K
DGICB
4784
Donegal Group Class B
DGICB
$891M
$6.03K ﹤0.01%
415
-681
-62% -$9.25K
FEMY icon
4785
Femasys
FEMY
$7.1M
$6K ﹤0.01%
308
-182
-37% -$4.47K
JHMM icon
4786
John Hancock Multifactor Mid Cap ETF
JHMM
$6.13B
$6K ﹤0.01%
114
-4,215
-97% -$203K
XELA
4787
DELISTED
Exela Technologies, Inc. Common Stock
XELA
$6K ﹤0.01%
+1,786
New +$5.92K
BOTJ icon
4788
Bank Of The James
BOTJ
$124M
$5.99K ﹤0.01%
490
-63
-11% -$654
AIFC
4789
AI Financial Corp
AIFC
$58.7M
$5.95K ﹤0.01%
10,719
+26
+0.2% +$11
SSKN
4790
DELISTED
Strata Skin Sciences
SSKN
$5.94K ﹤0.01%
1,080
+566
+110% +$2.94K
PRLH
4791
DELISTED
Pearl Holdings Acquisition Corp Class A Ordinary Shares
PRLH
$5.93K ﹤0.01%
554
+364
+192% +$3.91K
AFARU
4792
DELISTED
Aura FAT Projects Acquisition Corp Unit
AFARU
$5.92K ﹤0.01%
519
MMAT
4793
DELISTED
Meta Materials Inc. Common Stock
MMAT
$5.92K ﹤0.01%
+897
New +$10.7K
VERO
4794
DELISTED
Venus Concept
VERO
$5.88K ﹤0.01%
453
+150
+50% +$2.81K
BIV icon
4795
Vanguard Intermediate-Term Bond ETF
BIV
$28.8B
$5.88K ﹤0.01%
77
-11
-13% -$806
UNCY icon
4796
Unicycive Therapeutics
UNCY
$137M
$5.87K ﹤0.01%
676
+369
+120% +$2.41K
SIF icon
4797
SIFCO Industries
SIF
$130M
$5.87K ﹤0.01%
1,292
-352
-21% -$1.48K
ATER icon
4798
Aterian
ATER
$5.32M
$5.87K ﹤0.01%
1,401
+1,342
+2,275% +$5.18K
FTH
4799
Faeth Therapeutics
FTH
$773M
$5.84K ﹤0.01%
422
+59
+16% +$805
IXC icon
4800
iShares Global Energy ETF
IXC
$2.74B
$5.83K ﹤0.01%
+149
New +$5.92K

Similar funds

Tower Research Capital (TRC)'s Q4 2023 Portfolio in Review

As of Q4 2023, Tower Research Capital (TRC) held 6,444 positions worth $8.1B, up 153% from $3.2B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Tower Research Capital (TRC) deployed $4.22B of net new capital in Q4 2023, opening 505 new positions and adding to 3,426 existing holdings. Its largest new stake was Veralto: 28,523 shares worth $2.35M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares MSCI EAFE ETF, an estimated $21.7M trimmed.

  • Tower Research Capital (TRC)'s largest Q4 2023 buy was Veralto: 28,523 shares worth $2.35M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q4 2023, an estimated $314M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2023 reduction was iShares MSCI EAFE ETF, cutting an estimated $21.7M.
  • Tower Research Capital (TRC) fully exited Vanguard Morningstar Total Stock Market ETF in Q4 2023, selling an estimated $6.02M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 27% of its $8.1B portfolio in Q4 2023.
  • Tower Research Capital (TRC) opened 505 new positions and closed 524 in Q4 2023.
  • Tower Research Capital (TRC)'s portfolio value rose 153% quarter-over-quarter to $8.1B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2023, filed 13 Feb 2024.